Observational studyHeart and vessels2019

Primary and secondary prevention of stroke and systemic embolism with rivaroxaban in patients with non-valvular atrial fibrillation : Sub-analysis of the EXPAND Study.

Shinichiro Uchiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.